Avaliação de métodos de rompimento celular e de diferentes metais imobilizados em resina Streamline Chelating para purificação do antígeno 503 de Leishmania i. chagasi

Due to the development of biotechnology industry, there is a growing interest in purified recombinant antigens to obtain vaccines. However, for this application these antigens require a high degree of purity, thus, it is of great relevance the development of techniques that allow the reduction in th...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखक: Leitão, Ana Laura Oliveira de Sá
अन्य लेखक: Santos, Everaldo Silvino dos
स्वरूप: Dissertação
भाषा:por
प्रकाशित: Brasil
विषय:
ऑनलाइन पहुंच:https://repositorio.ufrn.br/jspui/handle/123456789/23391
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
विवरण
सारांश:Due to the development of biotechnology industry, there is a growing interest in purified recombinant antigens to obtain vaccines. However, for this application these antigens require a high degree of purity, thus, it is of great relevance the development of techniques that allow the reduction in the number of unitary operations required for the purification process, this would also allow a high recovery and a greater saving in obtaining bioproducts. The Expanded Bed Adsorption (EBA) has shown as a suitable alternative for downstream processing, once it is a simple and low cost chromatographic technique that integrates clarification, concentration and purification in a single operation. This study aims at evaluating the methods of cell disruption and the different metals immobilized in Streamline Chelating resin for purification of Leishmania i. chagasi 503 antigen by EBA as well as removing the lipopolysaccharides (endotoxin) released during the stage of cell disruption. Firstly, the best method of cell disruption to obtain intracellular protein was evaluated. The strategies studied using lysozyme, glass beads, urea and EDTA were evaluated through four experimental designs. Then, batch adsorption tests were carried out using five metal ions (Cu2+, Ni2+, Zn2+, Co2+ and Fe3+) at concentrations of 0.1, 0.5 and 0.8 M coupled in the Streamline chelating resin, selecting the metal that showed the best adsorption of the antigen for the assays using EBA. Then, the minimum amount of Triton X-114 tensioactive required in the EBA wash stage for LPS removal was estimated in order to obtain the 503 antigen free of this contaminant. Finally, EBA assays were performed in order to recover and purify the protein of interest. EBA experiments were carried out using a column of 2.6 cm in diameter (30 cm height), coupled to a peristaltic pump. The experimental plannings carried out to evaluate cell disruption, showed that higher amounts of total proteins and 503 antigen released were obtained for the urea method and that the only significant factor for this planning was the concentration corresponding to 8.0 M. As a result of the metal ion screening, copper (Cu2+) was the metal with the highest adsorption capacity of 503 antigen, presenting adsorption capacity values of 0.102, 0.128 and 0.111 mg / mL of adsorbent at concentrations of 0.1, 0.5 and 0.8 M, respectively. For the three analyzed conditions (0.01, 0.05 and 0.1% Triton X-114) in the EBA washing stage, the percentage of LPS removal was high and the minimum concentration used (0.01%) was enough to remove 99.70% of this contaminant. For the EBA test using isocratic elution (0.6 M imidazole) the results obtained showed a low recovery (3.0 %) of the 503 antigen. The step elution was then evaluated, initially in two steps, applying 0.6 M and then 1.0 M imidazole. However, this strategy has not yet been effective in recovering the protein of interest. A new assay was performed, with a total of three elution steps, using 0.3 and 0.6 M. This test showed that a recovery of 15.0% of the protein of interest and a purification factor of 3.0. Therefore, the immobilized metal ion affinity chromatography (IMAC) technique has been shown to be an efficient alternative in the recovery and purification of the 503 antigen from the homogenized E. coli unclarified.